-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Hippocampal sclerosis (HS) is the most common histopathological manifestation of drug-resistant medial temporal lobe epilepsy (mTLE), and its clinical features, pathogenesis, epilepsy occurrence, and treatment outcomes have been thoroughly studied
MRI allows to distinguish between HS and GO
Hippocampal sclerosis (HS) is the most common histopathological manifestation of drug-resistant medial temporal lobe epilepsy (mTLE), and its clinical features, pathogenesis, epilepsy occurrence, and treatment outcomes have been thoroughly studied
Frequency of preoperative memory impairment
MRI allows to distinguish between HS and GO
Changes in individual memory from preoperative to postoperative evaluation
Functional differences between GO and HS have not been resolved but are relevant
The clinical differences were obvious, with the GO group having a late age of seizures (18±12 vs 12±9 years) and fewer postoperative seizures (63% vs 82%)
Preoperative memory manifestations and postoperative memory outcomes
Compared with HS, GO is characterized by (1) a later seizure, (2) less pronounced and non-specific memory damage before surgery, (3) less successful surgical results, and (4) more significant